{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:14:52Z","timestamp":1792293292277,"version":"4.4.0"},"reference-count":201,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.nut.2022.111829","type":"journal-article","created":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T01:22:04Z","timestamp":1661044924000},"page":"111829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Contribution of skeletal muscle to cancer immunotherapy: A focus on muscle function, inflammation, and microbiota"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5748-585X","authenticated-orcid":false,"given":"Yuanle","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhujuan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nut.2022.111829_bib0001","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.nut.2022.111829_bib0002","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/jcsm.12538","article-title":"Body composition is prognostic and predictive of ipilimumab activity in metastatic melanoma","volume":"11","author":"Chu","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2022.111829_bib0003","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3390\/cancers12051230","article-title":"The effects of obesity on anti-cancer immunity and cancer immunotherapy","volume":"12","author":"Woodall","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.nut.2022.111829_bib0004","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.nut.2022.111829_bib0005","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.4049\/jimmunol.165.3.1352","article-title":"CTLA-4 can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression","volume":"165","author":"Carreno","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.nut.2022.111829_bib0006","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s13046-019-1259-z","article-title":"Combination of CTLA-4 and PD-1 blockers for treatment of cancer","volume":"38","author":"Rotte","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.nut.2022.111829_bib0007","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1084\/jem.188.1.205","article-title":"B7\u20131 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28","volume":"188","author":"Fallarino","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.nut.2022.111829_bib0008","first-page":"11","article-title":"The complex interaction between the tumor micro-environment and immune checkpoints in breast cancer","author":"Barriga","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.nut.2022.111829_bib0009","series-title":"In The Molecular Basis of Cancer","first-page":"695","article-title":"Cancer and the cellular immune response","author":"Hwu","year":"2015"},{"key":"10.1016\/j.nut.2022.111829_bib0010","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1158\/1078-0432.CCR-14-1860","article-title":"Immune escape mechanisms as a guide for cancer immunotherapy","volume":"21","author":"Beatty","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nut.2022.111829_bib0011","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.nut.2022.111829_bib0012","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.cell.2015.07.045","article-title":"PD-1 Blockers","volume":"162","author":"Wolchok","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.nut.2022.111829_bib0013","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nut.2022.111829_bib0014","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.immuni.2019.12.011","article-title":"Top 10 challenges in cancer immunotherapy","volume":"52","author":"Hegde","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.nut.2022.111829_bib0015","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.semcancer.2019.12.026","article-title":"Roles of microbiota in response to cancer immunotherapy","volume":"65","author":"Inamura","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.nut.2022.111829_bib0016","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nut.2022.111829_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112674","article-title":"Hyperprogression under immunotherapy","volume":"20","author":"Frelaut","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nut.2022.111829_bib0018","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.nut.2022.111829_bib0019","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/jcsm.12379","article-title":"The evolution of body composition in oncology-epidemiology, clinical trials, and the future of patient care: facts and numbers","volume":"9","author":"Brown","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2022.111829_bib0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1158\/1055-9965.EPI-16-0439","article-title":"The obesity paradox in cancer\u2014moving beyond BMI","volume":"26","author":"Strulov Shachar","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.nut.2022.111829_bib0021","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/onco.13922","article-title":"Body Composition as an independent predictive and prognostic biomarker in advanced urothelial carcinoma patients treated with immune checkpoint inhibitors","volume":"26","author":"Martini","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.nut.2022.111829_bib0022","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ymgme.2017.04.012","article-title":"Protein intake and physical activity are associated with body composition in individuals with phenylalanine hydroxylase deficiency","volume":"121","author":"Jani","year":"2017","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nut.2022.111829_bib0023","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1158\/0008-5472.CAN-17-3287","article-title":"The importance of body composition in explaining the overweight paradox in cancer-counterpoint","volume":"78","author":"Caan","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.nut.2022.111829_bib0024","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrclinonc.2013.120","article-title":"Clinical management of obese patients with cancer","volume":"10","author":"Tao","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.nut.2022.111829_bib0025","first-page":"1","article-title":"Obesity: preventing and managing the global epidemic. Report of a WHO consultation","volume":"894","year":"2000","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.nut.2022.111829_bib0026","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"with the International Agency for Research on Cancer Handbook Working Group. Body fatness and cancer\u2014viewpoint of the IARC Working Group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nut.2022.111829_bib0027","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1634\/theoncologist.2009-0285","article-title":"Obesity and cancer","volume":"15","author":"Wolin","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.nut.2022.111829_bib0028","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/291546","article-title":"Obesity as a major risk factor for cancer","volume":"2013","author":"De Pergola","year":"2013","journal-title":"J Obes"},{"key":"10.1016\/j.nut.2022.111829_bib0029","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1136\/bmj.39367.495995.AE","article-title":"wiith the Million Women Study Commission. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study","volume":"335","author":"Reeves","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.nut.2022.111829_bib0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1749-6632.2012.06750.x","article-title":"Obesity and cancer risk: evidence, mechanisms, and recommendations","volume":"1271","author":"Vucenik","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nut.2022.111829_bib0031","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.4049\/jimmunol.0903220","article-title":"Diet-induced obesity impairs the T cell memory response to influenza virus infection","volume":"184","author":"Karlsson","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.nut.2022.111829_bib0032","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1470-2045(18)30078-0","article-title":"Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis","volume":"19","author":"McQuade","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.nut.2022.111829_bib0033","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40425-019-0527-y","article-title":"A multicenter study of body mass index in cancer patients treated with anti-PD-1\/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable","volume":"7","author":"Cortellini","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.nut.2022.111829_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204729","article-title":"Body mass index may predict the response to ipilimumab in metastatic melanoma: an observational multi-centre study","volume":"13","author":"Richtig","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.nut.2022.111829_bib0035","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s40425-019-0699-5","article-title":"The complex relationship between body mass index and response to immune checkpoint inhibition in metastatic melanoma patients","volume":"7","author":"Donnelly","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.nut.2022.111829_bib0036","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41591-018-0221-5","article-title":"Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade","volume":"25","author":"Wang","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.nut.2022.111829_bib0037","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41591-018-0337-7","article-title":"Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma","volume":"25","author":"Cloughesy","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.nut.2022.111829_bib0038","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.nut.2022.111829_bib0039","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1152\/physrev.00030.2014","article-title":"Obesity and diabetes: the increased risk of cancer and cancer-related mortality","volume":"95","author":"Gallagher","year":"2015","journal-title":"Physiol Rev"},{"key":"10.1016\/j.nut.2022.111829_bib0040","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","article-title":"Inflammatory mechanisms in obesity","volume":"29","author":"Gregor","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.nut.2022.111829_bib0041","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.2019.0463","article-title":"The surprisingly positive association between obesity and cancer immunotherapy efficacy","volume":"321","author":"Murphy","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.nut.2022.111829_bib0042","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.3390\/nu11122979","article-title":"Herbal medicines attenuate PD-L1 expression to induce anti-proliferation in obesity-related cancers","volume":"11","author":"Yang","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.nut.2022.111829_bib0043","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s40425-019-0512-5","article-title":"Complex inter-relationship of body mass index, gender and serum creatinine on survival: exploring the obesity paradox in melanoma patients treated with checkpoint inhibition","volume":"7","author":"Naik","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.nut.2022.111829_bib0044","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.4049\/jimmunol.1701738","article-title":"Cutting edge: elevated leptin during diet-induced obesity reduces the efficacy of tumor immunotherapy","volume":"201","author":"Murphy","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.nut.2022.111829_bib0045","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/s42255-019-0116-x","article-title":"Skeletal muscle inefficiency protects against obesity","volume":"1","author":"Li","year":"2019","journal-title":"Nat Metab"},{"key":"10.1016\/j.nut.2022.111829_bib0046","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s40279-017-0845-5","article-title":"Assessing the role of muscle protein breakdown in response to nutrition and exercise in humans","volume":"48","author":"Tipton","year":"2018","journal-title":"Sports Med"},{"key":"10.1016\/j.nut.2022.111829_bib0047","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1111\/febs.12253","article-title":"Mechanisms regulating skeletal muscle growth and atrophy","volume":"280","author":"Schiaffino","year":"2013","journal-title":"FEBS J"},{"key":"10.1016\/j.nut.2022.111829_bib0048","doi-asserted-by":"crossref","first-page":"7399","DOI":"10.1113\/JP272857","article-title":"Synchronous deficits in cumulative muscle protein synthesis and ribosomal biogenesis underlie age-related anabolic resistance to exercise in humans","volume":"594","author":"Brook","year":"2016","journal-title":"J Physiol"},{"key":"10.1016\/j.nut.2022.111829_bib0049","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2337\/diab.32.7.675","article-title":"Splanchnic and peripheral disposal of oral glucose in man","volume":"32","author":"Katz","year":"1983","journal-title":"Diabetes"},{"key":"10.1016\/j.nut.2022.111829_bib0050","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.2337\/db17-0077","article-title":"Rab8a deficiency in skeletal muscle causes hyperlipidemia and hepatosteatosis by impairing muscle lipid uptake and storage","volume":"66","author":"Chen","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.nut.2022.111829_bib0051","doi-asserted-by":"crossref","first-page":"eaav4116","DOI":"10.1126\/sciadv.aav4116","article-title":"Targeting RalGAPalpha1 in skeletal muscle to simultaneously improve postprandial glucose and lipid control","volume":"5","author":"Chen","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.nut.2022.111829_bib0052","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jcsm.12104","article-title":"Doxorubicin caused severe hyperglycaemia and insulin resistance, mediated by inhibition in AMPk signalling in skeletal muscle","volume":"7","author":"de Lima Junior","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2022.111829_bib0053","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1172\/JCI111938","article-title":"Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent diabetes mellitus","volume":"76","author":"DeFronzo","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nut.2022.111829_bib0054","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.diabet.2009.02.002","article-title":"Is skeletal muscle mitochondrial dysfunction a cause or an indirect consequence of insulin resistance in humans?","volume":"35","author":"Dumas","year":"2009","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.nut.2022.111829_bib0055","doi-asserted-by":"crossref","first-page":"e13516","DOI":"10.1111\/apha.13516","article-title":"Pathophysiological mechanisms explaining poor clinical outcome of older cancer patients with low skeletal muscle mass","volume":"231","author":"Looijaard","year":"2021","journal-title":"Acta Physiol"},{"key":"10.1016\/j.nut.2022.111829_bib0056","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/phrs.1999.0568","article-title":"Effect of streptozotocin-induced hyperglycaemia on intravenous pharmacokinetics and acute cardiotoxicity of doxorubicin in rats","volume":"41","author":"Al-Shabanah","year":"2000","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.nut.2022.111829_bib0057","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.mrfmmm.2004.05.011","article-title":"DNA damage and repair in type 2 diabetes mellitus","volume":"554","author":"Blasiak","year":"2004","journal-title":"Mutat Res"},{"key":"10.1016\/j.nut.2022.111829_bib0058","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/j.2040-4603.2020.tb00136.x","article-title":"Role of skeletal muscle in insulin resistance and glucose uptake","volume":"10","author":"Merz","year":"2020","journal-title":"Compr Physiol"},{"key":"10.1016\/j.nut.2022.111829_bib0059","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.bbrc.2019.01.024","article-title":"Overexpression of Interleukin-15 exhibits improved glucose tolerance and promotes GLUT4 translocation via AMP-Activated protein kinase pathway in skeletal muscle","volume":"509","author":"Fujimoto","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nut.2022.111829_bib0060","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1210\/jc.2004-0603","article-title":"Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro","volume":"89","author":"Trujillo","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nut.2022.111829_bib0061","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.2337\/db05-1404","article-title":"Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase","volume":"55","author":"Carey","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.nut.2022.111829_bib0062","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.bbagen.2006.09.001","article-title":"Interleukin-15 increases glucose uptake in skeletal muscle. An antidiabetogenic effect of the cytokine","volume":"1760","author":"Busquets","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nut.2022.111829_bib0063","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1038\/oncsis.2016.3","article-title":"Understanding cachexia as a cancer metabolism syndrome","volume":"5","author":"Porporato","year":"2016","journal-title":"Oncogenesis"},{"key":"10.1016\/j.nut.2022.111829_bib0064","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/BF00235103","article-title":"Gender differences in strength and muscle fiber characteristics","volume":"66","author":"Miller","year":"1993","journal-title":"Eur J Appl Physiol Occup Physiol"},{"key":"10.1016\/j.nut.2022.111829_bib0065","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/ajcn\/35.5.1192","article-title":"Muscle mass: reliable indicator of protein-energy malnutrition severity and outcome","volume":"35","author":"Heymsfield","year":"1982","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nut.2022.111829_bib0066","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejca.2015.12.030","article-title":"Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review","volume":"57","author":"Shachar","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.nut.2022.111829_bib0067","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0261-5614(94)90009-4","article-title":"Glutamine requirements in the generation of lymphokine-activated killer cells","volume":"13","author":"Juretic","year":"1994","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nut.2022.111829_bib0068","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1182\/blood.V86.4.1564.bloodjournal8641564","article-title":"Influence of glutamine on the phenotype and function of human monocytes","volume":"86","author":"Spittler","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.nut.2022.111829_bib0069","doi-asserted-by":"crossref","first-page":"S384","DOI":"10.1097\/CCM.0b013e3181b6f8a5","article-title":"Muscle in defense","volume":"37","author":"Lightfoot","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.nut.2022.111829_bib0070","doi-asserted-by":"crossref","first-page":"e1792","DOI":"10.1038\/cddis.2015.162","article-title":"T-cell exhaustion in the tumor microenvironment","volume":"6","author":"Jiang","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.nut.2022.111829_bib0071","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1634\/theoncologist.2016-0066","article-title":"The prevalence and prognostic value of low muscle mass in cancer patients: a review of the literature","volume":"21","author":"Rier","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.nut.2022.111829_bib0072","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/ageing\/afz046","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.nut.2022.111829_bib0073","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/1759-7714.12965","article-title":"Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: a \"hypothesis-generator\" preliminary report","volume":"10","author":"Cortellini","year":"2019","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.nut.2022.111829_bib0074","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","article-title":"Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups \"cachexia-anorexia in chronic wasting diseases\" and \"nutrition in geriatrics","volume":"29","author":"Muscaritoli","year":"2010","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nut.2022.111829_bib0075","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/jcsm.12167","article-title":"Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016","volume":"7","author":"von Haehling","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2022.111829_bib0076","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/annonc\/mdx271","article-title":"Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy","volume":"28","author":"Bozzetti","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.nut.2022.111829_bib0077","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1158\/1078-0432.CCR-06-3067","article-title":"Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity","volume":"13","author":"Prado","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nut.2022.111829_bib0078","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/bjc.2013.58","article-title":"Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients","volume":"108","author":"Huillard","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nut.2022.111829_bib0079","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/ajcn\/79.4.613","article-title":"Nutritional assessment: lean body mass depletion at hospital admission is associated with an increased length of stay","volume":"79","author":"Pichard","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nut.2022.111829_bib0080","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/bjc.2012.350","article-title":"Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery","volume":"107","author":"Lieffers","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nut.2022.111829_bib0081","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1158\/1078-0432.CCR-09-1525","article-title":"Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer","volume":"15","author":"Tan","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nut.2022.111829_bib0082","doi-asserted-by":"crossref","first-page":"535","DOI":"10.18632\/aging.100482","article-title":"Sarcopenia, obesity, and natural killer cell immune senescence in aging: altered cytokine levels as a common mechanism","volume":"4","author":"Lutz","year":"2012","journal-title":"Aging"},{"key":"10.1016\/j.nut.2022.111829_bib0083","doi-asserted-by":"crossref","first-page":"e528","DOI":"10.1634\/theoncologist.2019-0751","article-title":"Combined effect of sarcopenia and systemic inflammation on survival in patients with advanced stage cancer treated with immunotherapy","volume":"25","author":"Bilen","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.nut.2022.111829_bib0084","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.nut.2022.111829_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107694","article-title":"Combination therapy with PD-1\/PD-L1 blockade in non-small cell lung cancer: strategies and mechanisms","volume":"219","author":"Huang","year":"2021","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.nut.2022.111829_bib0086","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3390\/jcm8040450","article-title":"Association of sarcopenia with and efficacy of Anti-PD-1\/PD-L1 therapy in non-small-cell lung cancer","volume":"8","author":"Nishioka","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.nut.2022.111829_bib0087","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1038\/s41598-019-39120-6","article-title":"Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors: a preliminary retrospective study","volume":"9","author":"Shiroyama","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.nut.2022.111829_bib0088","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s00432-020-03146-5","article-title":"Clinical impact of skeletal muscle area in patients with non-small cell lung cancer treated with anti-PD-1 inhibitors","volume":"146","author":"Takada","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.nut.2022.111829_bib0089","article-title":"Desensitizing effect of cancer cachexia on immune checkpoint inhibitors in patients with advanced NSCLC","volume":"1","author":"Miyawaki","year":"2020","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.nut.2022.111829_bib0090","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.21037\/tlcr-21-460","article-title":"Cancer cachexia syndrome and clinical outcome in patients with metastatic non-small cell lung cancer treated with PD-1\/PD-L1 inhibitors: results from a prospective, observational study","volume":"10","author":"Rounis","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.nut.2022.111829_bib0091","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S1470-2045(16)30366-7","article-title":"Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial","volume":"17","author":"Hodi","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.nut.2022.111829_bib0092","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000821","article-title":"Impact of body composition on outcomes from anti-PD1 +\/- anti-CTLA-4 treatment in melanoma","volume":"8","author":"Young","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.nut.2022.111829_bib0093","doi-asserted-by":"crossref","first-page":"9728","DOI":"10.1038\/s41598-019-46189-6","article-title":"Macroangiopathy is a positive predictive factor for response to immunotherapy","volume":"9","author":"Deike-Hofmann","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.nut.2022.111829_bib0094","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10147-020-01833-4","article-title":"Association between skeletal muscle loss and the response to nivolumab immunotherapy in advanced gastric cancer patients","volume":"26","author":"Kano","year":"2021","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.nut.2022.111829_bib0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.701668","article-title":"Prognostic impact of sarcopenia and radiotherapy in patients with advanced gastric cancer treated with anti-PD-1 antibody","volume":"12","author":"Kim","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.nut.2022.111829_bib0096","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10120-020-01124-x","article-title":"Prognostic significance of sarcopenia in microsatellite-stable gastric cancer patients treated with programmed death-1 inhibitors","volume":"24","author":"Kim","year":"2021","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.nut.2022.111829_bib0097","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/COC.0000000000000787","article-title":"Impact of sarcopenia, BMI, and inflammatory biomarkers on survival in advanced hepatocellular carcinoma treated with anti-PD-1 antibody","volume":"44","author":"Akce","year":"2021","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.nut.2022.111829_bib0098","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejca.2016.05.031","article-title":"Rapid and objective CT scan prognostic scoring identifies metastatic patients with long-term clinical benefit on anti-PD-1\/-L1 therapy","volume":"65","author":"Dercle","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.nut.2022.111829_bib0099","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1200\/JCO.2015.66.1389","article-title":"Safety profile of nivolumab monotherapy: a pooled analysis of patients with advanced melanoma","volume":"35","author":"Weber","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nut.2022.111829_bib0100","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/bjc.2016.431","article-title":"The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma","volume":"116","author":"Daly","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nut.2022.111829_bib0101","doi-asserted-by":"crossref","first-page":"9","DOI":"10.14740\/wjon1225","article-title":"Sarcopenia and visceral adiposity did not affect efficacy of immune-checkpoint inhibitor monotherapy for pretreated patients with advanced non-small cell lung cancer","volume":"11","author":"Minami","year":"2020","journal-title":"World J Oncol"},{"key":"10.1016\/j.nut.2022.111829_bib0102","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2021.111544","article-title":"Inflammation and sarcopenia: a focus on circulating inflammatory cytokines","volume":"154","author":"Pan","year":"2021","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.nut.2022.111829_bib0103","doi-asserted-by":"crossref","first-page":"e12828","DOI":"10.1111\/acel.12828","article-title":"Myeloid cell-derived tumor necrosis factor-alpha promotes sarcopenia and regulates muscle cell fusion with aging muscle fibers","volume":"17","author":"Wang","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.nut.2022.111829_bib0104","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.amjmed.2005.10.049","article-title":"Inflammatory markers and loss of muscle mass and strength","volume":"119","author":"Schaap","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.nut.2022.111829_bib0105","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.clnu.2020.05.005","article-title":"High neutrophil to lymphocytes ratio is associated with sarcopenia risk in hospitalized cancer patients","volume":"40","author":"Borges","year":"2021","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nut.2022.111829_bib0106","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2020.110832","article-title":"Sex-different associations between serum homocysteine, high-sensitivity C-reactive protein and sarcopenia: results from I-Lan Longitudinal Aging Study","volume":"132","author":"Lee","year":"2020","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.nut.2022.111829_bib0107","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40520-017-0848-y","article-title":"The relationship between plasma interleukin-15 levels and sarcopenia in outpatient older people","volume":"30","author":"Yalcin","year":"2018","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.nut.2022.111829_bib0108","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1186\/s40064-016-2197-2","article-title":"Skeletal muscle wasting and renewal: a pivotal role of myokine IL-6","volume":"5","author":"Belizario","year":"2016","journal-title":"Springerplus"},{"key":"10.1016\/j.nut.2022.111829_bib0109","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.cmet.2016.10.010","article-title":"Tumor-induced IL-6 reprograms host metabolism to suppress anti-tumor immunity","volume":"24","author":"Flint","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.nut.2022.111829_bib0110","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1158\/0008-5472.CAN-15-0255","article-title":"Classifying cancers based on T-cell infiltration and PD-L1","volume":"75","author":"Teng","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.nut.2022.111829_bib0111","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1158\/2326-6066.CIR-17-0175","article-title":"Subversion of NK-cell and TNFalpha immune surveillance drives tumor recurrence","volume":"5","author":"Kottke","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.nut.2022.111829_bib0112","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1249559","article-title":"Clinical implication of tumor-associated and immunological parameters in melanoma patients treated with ipilimumab","volume":"5","author":"Damuzzo","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.nut.2022.111829_bib0113","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1158\/0008-5472.CAN-18-0118","article-title":"Combined blockade of IL6 and PD-1\/PD-L1 signaling abrogates mutual regulation of their immunosuppressive effects in the tumor microenvironment","volume":"78","author":"Tsukamoto","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.nut.2022.111829_bib0114","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jdermsci.2016.12.019","article-title":"Serum level of interleukin-6 is increased in nivolumab-associated psoriasiform dermatitis and tumor necrosis factor-alpha is a biomarker of nivolumab recativity","volume":"86","author":"Tanaka","year":"2017","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.nut.2022.111829_bib0115","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1515\/hsz-2017-0217","article-title":"TGF-beta requires the activation of canonical and non-canonical signalling pathways to induce skeletal muscle atrophy","volume":"399","author":"Abrigo","year":"2018","journal-title":"Biol Chem"},{"key":"10.1016\/j.nut.2022.111829_bib0116","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/jcsm.12441","article-title":"Tumour-derived transforming growth factor-beta signalling contributes to fibrosis in patients with cancer cachexia","volume":"10","author":"Lima","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2022.111829_bib0117","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature25492","article-title":"TGFbeta drives immune evasion in genetically reconstituted colon cancer metastasis","volume":"554","author":"Tauriello","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.nut.2022.111829_bib0118","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.nut.2022.111829_bib0119","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/acel.12350","article-title":"Increases of M2a macrophages and fibrosis in aging muscle are influenced by bone marrow aging and negatively regulated by muscle-derived nitric oxide","volume":"14","author":"Wang","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.nut.2022.111829_bib0120","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.clnu.2020.09.021","article-title":"Are body fat and inflammatory markers independently associated with age-related muscle changes?","volume":"40","author":"Nascimento","year":"2021","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nut.2022.111829_bib0121","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1038\/s41467-017-02358-7","article-title":"TNFalpha blockade overcomes resistance to anti-PD-1 in experimental melanoma","volume":"8","author":"Bertrand","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.nut.2022.111829_bib0122","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-0029-1212086","article-title":"Mechanisms of TNF-alpha-induced insulin resistance","volume":"107","author":"Hotamisligil","year":"1999","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.nut.2022.111829_bib0123","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/39335","article-title":"Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function","volume":"389","author":"Uysal","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.nut.2022.111829_bib0124","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117304","article-title":"Decreased secretion of tumor necrosis factor-alpha attenuates macrophages-induced insulin resistance in skeletal muscle","volume":"244","author":"Bu","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.nut.2022.111829_bib0125","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nri1901","article-title":"The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design","volume":"6","author":"Waldmann","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nut.2022.111829_bib0126","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.2527\/jas.2007-0458","article-title":"Interleukin-15: a muscle-derived cytokine regulating fat-to-lean body composition","volume":"86","author":"Quinn","year":"2008","journal-title":"J Anim Sci"},{"key":"10.1016\/j.nut.2022.111829_bib0127","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3389\/fimmu.2018.00440","article-title":"Human body composition and immunity: visceral adipose tissue produces IL-15 and muscle strength inversely correlates with NK cell function in elderly humans","volume":"9","author":"Al-Attar","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.nut.2022.111829_bib0128","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2016.04.025","article-title":"Identification of a subset of human natural killer cells expressing high levels of programmed death 1: a phenotypic and functional characterization","volume":"139","author":"Pesce","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.nut.2022.111829_bib0129","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/nm.3961","article-title":"Excess TGF-beta mediates muscle weakness associated with bone metastases in mice","volume":"21","author":"Waning","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.nut.2022.111829_bib0130","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/carcin\/bgp127","article-title":"Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability","volume":"30","author":"Colotta","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.nut.2022.111829_bib0131","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.maturitas.2016.11.006","article-title":"Inflammation and sarcopenia: a systematic review and meta-analysis","volume":"96","author":"Bano","year":"2017","journal-title":"Maturitas"},{"key":"10.1016\/j.nut.2022.111829_bib0132","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nut.2022.111829_bib0133","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00262-010-0855-8","article-title":"Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity","volume":"59","author":"Ostrand-Rosenberg","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.nut.2022.111829_bib0134","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.currproblcancer.2016.12.002","article-title":"Targeting the PD-1\/PD-L1 axis in non-small cell lung cancer","volume":"41","author":"Kumar","year":"2017","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.nut.2022.111829_bib0135","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1002\/eji.201040895","article-title":"The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity","volume":"40","author":"Youn","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.nut.2022.111829_bib0136","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-06-2197","article-title":"Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma","volume":"13","author":"Ochoa","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nut.2022.111829_bib0137","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4049\/jimmunol.166.1.678","article-title":"Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer","volume":"166","author":"Almand","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.nut.2022.111829_bib0138","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/carcin\/bgv123","article-title":"Immunosuppression associated with chronic inflammation in the tumor microenvironment","volume":"36","author":"Wang","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.nut.2022.111829_bib0139","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/cas.14069","article-title":"Regulatory T cells in cancer: can Treg cells be a new therapeutic target?","volume":"110","author":"Ohue","year":"2019","journal-title":"Cancer Sci"},{"key":"10.1016\/j.nut.2022.111829_bib0140","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.nut.2022.111829_bib0141","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ebiom.2019.10.034","article-title":"Skeletal muscle as potential central link between sarcopenia and immune senescence","volume":"49","author":"Nelke","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.nut.2022.111829_bib0142","doi-asserted-by":"crossref","first-page":"E453","DOI":"10.1152\/ajpendo.00553.2012","article-title":"Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications","volume":"304","author":"Pillon","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.nut.2022.111829_bib0143","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.nut.2022.111829_bib0144","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.3390\/cancers14102381","article-title":"Immunotherapy and microbiota for targeting of liver tumor-initiating stem-like cells","volume":"14","author":"Machida","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.nut.2022.111829_bib0145","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrc.2017.13","article-title":"Microbiota: a key orchestrator of cancer therapy","volume":"17","author":"Roy","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.nut.2022.111829_bib0146","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.nut.2022.111829_bib0147","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1126\/science.1240527","article-title":"Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment","volume":"342","author":"Iida","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.nut.2022.111829_bib0148","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.1240537","article-title":"The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide","volume":"342","author":"Viaud","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.nut.2022.111829_bib0149","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.smim.2006.10.002","article-title":"Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota","volume":"19","author":"Smith","year":"2007","journal-title":"Semin Immunol"},{"key":"10.1016\/j.nut.2022.111829_bib0150","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/jcsm.12804","article-title":"Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients","volume":"12","author":"Ubachs","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nut.2022.111829_bib0151","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.3390\/cells10113164","article-title":"High-fat, Western-style diet, systemic inflammation, and gut microbiota: a narrative review","volume":"10","author":"Malesza","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.nut.2022.111829_bib0152","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature11234","article-title":"Human Microbiome Project C. Structure, function and diversity of the healthy human microbiome","volume":"486","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.nut.2022.111829_bib0153","doi-asserted-by":"crossref","first-page":"eeav1892","DOI":"10.1126\/scitranslmed.aav1892","article-title":"The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs","volume":"11","author":"Virtue","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.nut.2022.111829_bib0154","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.ccell.2018.03.004","article-title":"The intestinal microbiota in colorectal cancer","volume":"33","author":"Tilg","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.nut.2022.111829_bib0155","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/ismej.2015.209","article-title":"Synbiotic approach restores intestinal homeostasis and prolongs survival in leukaemic mice with cachexia","volume":"10","author":"Bindels","year":"2016","journal-title":"ISME J"},{"key":"10.1016\/j.nut.2022.111829_bib0156","doi-asserted-by":"crossref","first-page":"18224","DOI":"10.18632\/oncotarget.24804","article-title":"Increased gut permeability in cancer cachexia: mechanisms and clinical relevance","volume":"9","author":"Bindels","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.nut.2022.111829_bib0157","doi-asserted-by":"crossref","first-page":"12321","DOI":"10.1038\/s41598-018-30569-5","article-title":"Klebsiella oxytoca expands in cancer cachexia and acts as a gut pathobiont contributing to intestinal dysfunction","volume":"8","author":"Potgens","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.nut.2022.111829_bib0158","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s42255-018-0017-4","article-title":"Microbial regulation of organismal energy homeostasis","volume":"1","author":"Cani","year":"2019","journal-title":"Nat Metab"},{"key":"10.1016\/j.nut.2022.111829_bib0159","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/gutjnl-2018-316161","article-title":"Distal versus proximal intestinal short-chain fatty acid release in man","volume":"68","author":"Neis","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.nut.2022.111829_bib0160","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","article-title":"Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism","volume":"7","author":"Morrison","year":"2016","journal-title":"Gut Microbes"},{"key":"10.1016\/j.nut.2022.111829_bib0161","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrendo.2015.128","article-title":"Short-chain fatty acids in control of body weight and insulin sensitivity","volume":"11","author":"Canfora","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.nut.2022.111829_bib0162","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s13668-019-00281-5","article-title":"Targeting carbohydrates and polyphenols for a healthy microbiome and healthy weight","volume":"8","author":"Van Hul","year":"2019","journal-title":"Curr Nutr Rep"},{"key":"10.1016\/j.nut.2022.111829_bib0163","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/nutrit\/nuw067","article-title":"Role of short-chain fatty acids in colonic inflammation, carcinogenesis, and mucosal protection and healing","volume":"75","author":"van der Beek","year":"2017","journal-title":"Nutr Rev"},{"key":"10.1016\/j.nut.2022.111829_bib0164","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1038\/cti.2016.17","article-title":"Regulation of immune cell function by short-chain fatty acids","volume":"5","author":"Correa-Oliveira","year":"2016","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.nut.2022.111829_bib0165","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.intimp.2017.07.023","article-title":"Sodium butyrate inhibits the NF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an IL-10 independent manner","volume":"51","author":"Lee","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.nut.2022.111829_bib0166","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan5662","article-title":"The gut microbiota influences skeletal muscle mass and function in mice","volume":"11","author":"Lahiri","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.nut.2022.111829_bib0167","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2021.101508","article-title":"Gut microbiota and metabolic aspects of cancer cachexia","volume":"35","author":"Ziemons","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.nut.2022.111829_bib0168","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1053\/j.gastro.2016.06.022","article-title":"Loss of junctional adhesion molecule a promotes severe steatohepatitis in mice on a diet high in saturated fat, fructose, and cholesterol","volume":"151","author":"Rahman","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nut.2022.111829_bib0169","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.3390\/ijms19092809","article-title":"The dynamic changes of gut microbiota in Muc2 deficient mice","volume":"19","author":"Wu","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nut.2022.111829_bib0170","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41575-018-0025-6","article-title":"Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer","volume":"15","author":"Cani","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.nut.2022.111829_bib0171","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.bbadis.2011.08.010","article-title":"Gut barrier dysfunction in the Apc mouse model of colon cancer cachexia","volume":"1812","author":"Puppa","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nut.2022.111829_bib0172","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1089\/jir.2013.0020","article-title":"The altered tight junctions: an important gateway of bacterial translocation in cachexia patients with advanced gastric cancer","volume":"34","author":"Jiang","year":"2014","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.nut.2022.111829_bib0173","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113399","article-title":"Cortex periplocae modulates the gut microbiota to restrict colitis and colitis-associated colorectal cancer via suppression of pathogenic Th17 cells","volume":"153","author":"Lin","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.nut.2022.111829_bib0174","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.899161","article-title":"The efficacy of cancer immunotherapies is compromised by Helicobacter pylori infection","volume":"13","author":"Oster","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.nut.2022.111829_bib0175","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.aac4255","article-title":"Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.nut.2022.111829_bib0176","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3747\/co.26.5177","article-title":"Impact of the gut microbiome on immune checkpoint inhibitor efficacy-a systematic review","volume":"26","author":"Pierrard","year":"2019","journal-title":"Curr Oncol"},{"key":"10.1016\/j.nut.2022.111829_bib0177","first-page":"665","article-title":"An insight into the novel immunotherapy and targeted therapeutic strategies for hepatocellular carcinoma and cholangiocarcinoma","volume":"12","author":"Trifylli","year":"2022","journal-title":"Life (Basel)"},{"key":"10.1016\/j.nut.2022.111829_bib0178","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis","volume":"14","author":"Argiles","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.nut.2022.111829_bib0179","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1080\/14656566.2019.1622093","article-title":"Current pharmacotherapies for sarcopenia","volume":"20","author":"Hardee","year":"2019","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.nut.2022.111829_bib0180","doi-asserted-by":"crossref","DOI":"10.3390\/nu12061755","article-title":"Nutrition and sarcopenia\u2014what do we know?","volume":"12","author":"Ganapathy","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.nut.2022.111829_bib0181","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdx809","article-title":"Muscle protein anabolism in advanced cancer patients: response to protein and amino acids support, and to physical activity","volume":"29","author":"Antoun","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.nut.2022.111829_bib0182","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3945\/ajcn.114.105833","article-title":"Fish oil-derived n-3 PUFA therapy increases muscle mass and function in healthy older adults","volume":"102","author":"Smith","year":"2015","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nut.2022.111829_bib0183","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/ajcn\/75.4.611","article-title":"Vitamin D deficiency, muscle function, and falls in elderly people","volume":"75","author":"Janssen","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nut.2022.111829_bib0184","doi-asserted-by":"crossref","first-page":"e37971","DOI":"10.1371\/journal.pone.0037971","article-title":"Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model","volume":"7","author":"Bindels","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nut.2022.111829_bib0185","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1038\/s41396-021-00998-8","article-title":"Distinct composition and metabolic functions of human gut microbiota are associated with cachexia in lung cancer patients","volume":"15","author":"Ni","year":"2021","journal-title":"ISME J"},{"key":"10.1016\/j.nut.2022.111829_bib0186","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/biologics1020006","article-title":"Involvement of probiotics and postbiotics in the immune system modulation","volume":"1","author":"Ye\u015filyurt","year":"2021","journal-title":"Biologics"},{"key":"10.1016\/j.nut.2022.111829_bib0187","doi-asserted-by":"crossref","DOI":"10.3390\/nu13020389","article-title":"Gut-brain-microbiota axis: antibiotics and functional gastrointestinal disorders","volume":"13","author":"Karakan","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.nut.2022.111829_bib0188","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jso.24003","article-title":"Morphomics predicts response to ipilimumab in patients with stage IV melanoma","volume":"112","author":"Sabel","year":"2015","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.nut.2022.111829_bib0189","doi-asserted-by":"crossref","first-page":"8201","DOI":"10.2147\/CMAR.S210958","article-title":"Correlation of body composition by computerized tomography and metabolic parameters with survival of nivolumab-treated lung cancer patients","volume":"11","author":"Magri","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.nut.2022.111829_bib0190","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/s41598-020-58498-2","article-title":"Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1\/PD-L1 checkpoint inhibitors: a multicenter real-life study","volume":"10","author":"Cortellini","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.nut.2022.111829_bib0191","doi-asserted-by":"crossref","first-page":"e19059","DOI":"10.1097\/MD.0000000000019059","article-title":"Skeletal muscle mass predicts the outcome of nivolumab treatment for non-small cell lung cancer","volume":"99","author":"Tsukagoshi","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.nut.2022.111829_bib0192","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.lungcan.2020.03.003","article-title":"Cachexia - sarcopenia as a determinant of disease control rate and survival in non-small lung cancer patients receiving immune-checkpoint inhibitors","volume":"143","author":"Roch","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.nut.2022.111829_bib0193","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3390\/diagnostics10050310","article-title":"Clinical impact of sarcopenia and inflammatory\/nutritional markers in patients with unresectable metastatic urothelial carcinoma treated with pembrolizumab","volume":"10","author":"Shimizu","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.nut.2022.111829_bib0194","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejca.2020.05.005","article-title":"Survivorship in immune therapy: assessing toxicities, body composition and health-related quality of life among long-term survivors treated with antibodies to programmed death-1 receptor and its ligand","volume":"135","author":"Patrinely","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.nut.2022.111829_bib0195","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.21873\/anticanres.14528","article-title":"Higher BMI, but not sarcopenia, is associated with pembrolizumab-related toxicity in patients with advanced melanoma","volume":"40","author":"Hu","year":"2020","journal-title":"Anticancer Res"},{"key":"10.1016\/j.nut.2022.111829_bib0196","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/CAD.0000000000000982","article-title":"Impact of sarcopenia on the efficacy of pembrolizumab in patients with advanced urothelial carcinoma: a preliminary report","volume":"31","author":"Fukushima","year":"2020","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.nut.2022.111829_bib0197","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/cam4.3631","article-title":"Unfavorable impact of decreased muscle quality on the efficacy of immunotherapy for advanced non-small cell lung cancer","volume":"10","author":"Nishioka","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.nut.2022.111829_bib0198","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2020.109340","article-title":"Impact of CT-based body composition parameters at baseline, their early changes and response in metastatic cancer patients treated with immune checkpoint inhibitors","volume":"133","author":"Crombe","year":"2020","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.nut.2022.111829_bib0199","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3390\/jcm10071361","article-title":"Progressive sarcopenia correlates with poor response and outcome to immune checkpoint inhibitor therapy","volume":"10","author":"Loosen","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.nut.2022.111829_bib0200","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s10637-017-0464-x","article-title":"Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients","volume":"35","author":"Heidelberger","year":"2017","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.nut.2022.111829_bib0201","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejca.2019.11.003","article-title":"The impact of body composition parameters on severe toxicity of nivolumab","volume":"124","author":"Hirsch","year":"2020","journal-title":"Eur J Cancer"}],"container-title":["Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900722002428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900722002428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:19:58Z","timestamp":1760271598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899900722002428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":201,"alternative-id":["S0899900722002428"],"URL":"https:\/\/doi.org\/10.1016\/j.nut.2022.111829","relation":{},"ISSN":["0899-9007"],"issn-type":[{"value":"0899-9007","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contribution of skeletal muscle to cancer immunotherapy: A focus on muscle function, inflammation, and microbiota","name":"articletitle","label":"Article Title"},{"value":"Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nut.2022.111829","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111829"}}